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Summary
In C. elegans, the skn-1 gene encodes a transcription factor that
resembles mammalian Nrf2 and activates a detoxification
response. skn-1 promotes resistance to oxidative stress (Oxr)
and also increases lifespan, and it has been suggested that the
former causes the latter, consistent with the theory that oxida-
tive damage causes aging. Here, we report that effects of SKN-1
on Oxr and longevity can be dissociated. We also establish that
skn-1 expression can be activated by the DAF-16/FoxO transcrip-
tion factor, another central regulator of growth, metabolism, and
aging. Notably, skn-1 is required for Oxr but not increased
lifespan resulting from over-expression of DAF-16; concomi-
tantly, DAF-16 over-expression rescues the short lifespan of
skn-1 mutants but not their hypersensitivity to oxidative stress.
These results suggest that SKN-1 promotes longevity by a
mechanism other than protection against oxidative damage.
Key words: aging; C. elegans; oxidative stress; transcription
regulation.
Introduction, Results, Discussion
SKN-1 is the C. elegans functional ortholog of the mammalian Nrf
transcription factors. It protects against stress such that deletion or over-
expression of skn-1 results in animals that are hypersensitive or resistant,
respectively, to stress (Blackwell et al., 2015). skn-1 also protects against
aging: loss of skn-1 shortens lifespan and skn-1 over-expression or gain-
of-function usually increases lifespan (Blackwell et al., 2015; Tang &
Choe, 2015). As stress resistance and increased lifespan (Age) are often
correlated, one possibility is that protection against stress causes longer
life (Ristow & Schmeisser, 2011).
Correlated stress resistance and longevity is also observed in worms
with reduced insulin/IGF-1 signaling (rIIS), dependent upon the tran-
scription factor DAF-16/FoxO (Kenyon, 2010). Results from combined
mRNA and chromatin profiling suggest that DAF-16 acts as a central
regulator within a gene network (Schuster et al., 2010; Tullet, 2014).
Notably, although these predicted direct DAF-16 targets include few
effectors of stress resistance, one of them is skn-1 (Schuster et al.,
2010). Like daf-16, skn-1 contributes to rIIS Age and stress resistance
(Blackwell et al., 2015).
This raises the possibility that activation of skn-1 expression by DAF-
16 promotes stress resistance and, consequently, increased lifespan.
If skn-1 expression is activated by DAF-16, then SKN-1 could mediate
the phenotypic effects of DAF-16 activation. daf-16 over-expression (oe)
using zIs356, a multicopy transgene array, increases resistance to stress
(Henderson & Johnson, 2001) and extends lifespan (Qi et al., 2012). We
therefore assessed whether SKN-1 is required for daf-16(oe) stress
resistance and Age. First, we used zIs356 to compare the resistance of
daf-16(oe) and daf-16(oe); skn-1(zu135) worms to oxidative stress. daf-
16(oe) animals proved to be resistant to tert-butyl hydroperoxide (t-
BOOH) and sodium arsenite, and this resistance was dependent on skn-1
(Fig. 1A and 1B). Similar results were also obtained with respect to
paraquat resistance, although here skn-1 only partially suppressed the
resistance of daf-16(oe) (Fig. 1C). However, SKN-1 was dispensable for
daf-16(oe) resistance to heat (Fig. S1). Thus, daf-16(oe) wholly or
partially requires SKN-1 to promote Oxr but not thermotolerance.
Next we tested whether SKN-1 was required for daf-16(oe) Age. skn-
1(zu135) alone reduced lifespan but, strikingly, not in daf-16(oe) animals
(3 trials; Fig. 1D, Table S1). Thus, the effects of skn-1 on daf-16(oe) Age
and Oxr are separable. It is striking here that the life-shortening effects of
skn-1 are suppressed by daf-16(oe), even though the worms remain
sensitive to oxidative stress. This indicates that the life-shortening effect
of loss of function of skn-1 is not due to the concomitant increase in
sensitivity to oxidative stress.
We then sought to verify this unexpected conclusion using skn-1
(RNAi), and daf-16(oe) achieved by three means: zIs356,muEx176 (Pdaf-
16::daf-16a::gfp) or muEx227 (Pges-1::daf-16a::gfp, intestine-limited
over-expression) (Libina et al., 2003; Alic et al., 2014). In most trials,
skn-1(RNAi) either did not reduce daf-16(oe) Age (4/7 trials), or it
reduced lifespan to a similar extent in N2 and daf-16(oe) populations (2/
7 trials; P = 0.46, 0.88; Cox proportional hazard analysis [CPHA])
(Fig. 1E–G, Table S1). In only one trial did skn-1(RNAi) reduce lifespan
marginally more in the daf-16(oe) populations (P = 0.04, CPHA). By
contrast, skn-1(RNAi) significantly reduced N2 lifespan in all trials
(Table S1). Thus, in all RNAi trials, daf-16(oe) either fully or partially
suppressed the short lifespan resulting from skn-1 RNAi, consistent with
results with skn-1(zu135).
Effects of daf-16(oe) on aging can be masked by premature death
associated with daf-16(oe)-induced germline hyperplasia, but treatment
with an inhibitor of DNA replication 5-fluoro-2-deoxyuridine (FUDR)
prevents this, unmasking the effect of daf-16(oe) on lifespan (Qi et al.,
2012). One possibility is that skn-1 does not suppress daf-16(oe)
longevity because it also rescues the daf-16(oe) germline abnormality.
However, skn-1 did not alter the frequency of germ cells outside the
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basal gonad membrane (Fig. S2) arguing against this. Another possibility
is that skn-1 does not reduce daf-16(oe) lifespan because FUDR
suppresses effects of skn-1 on lifespan. However, the short lifespan on
FUDR of three different skn-1 mutants argues against this (Fig. S3A,
Table S1).
It is notable that in daf-2 mutants, where DAF-16 is activated,
longevity is skn-1 dependent, but in daf-2(+); daf-16(oe) worms it is not.
This could imply that daf-16(oe) Age is only SKN-1 dependent given rIIS.
To test this, we compared the life spans of daf-16(oe) and daf-16(oe);
skn-1 worms subjected to daf-2 RNAi. As expected, daf-2 RNAi greatly
extended the lifespan of WT worms and this was partially suppressed by
skn-1 (P < 0.0001) (Tullet et al., 2008). daf-2 RNAi also increased the
lifespan of daf-16(oe) worms but notably this was not suppressed by
skn-1 (Fig. S3B, Table S1). Unexpectedly, daf-16(oe) reduced the lifespan
of worms subjected to daf-2 RNAi (P < 0.0001 in each of 2 trials)
(Fig. S3B, Table S1), perhaps reflecting excessive DAF-16 activity. In
summary, it is not the case that longevity induced by increased DAF-16
activity is only SKN-1 dependent given rIIS. Moreover, daf-16(oe)
suppresses the SKN-1 dependence of rIIS longevity.
A long-standing theory in the aging field is that aging is caused by
accumulated oxidative damage, but some C. elegans studies have
argued against this (reviewed in Gems & Partridge, 2013). However,
SKN-1 not only promotes longevity but also resistance to pro-oxidants. If
protection against molecular damage promotes daf-16(oe) Age, then
our lifespan results could be explained by daf-16(oe) compensating for
loss of skn-1 by inducing other antioxidant defences. If correct, this
predicts that elevation of protein oxidation levels in skn-1 mutants
should be suppressed by daf-16(oe). We tested this by measuring protein
carbonyl levels in worm protein extracts. Although results were variable,
there was a trend toward skn-1 worms having increased levels of protein
oxidation compared to wild-type (WT), as seen previously (Rea et al.,
2007); this was also seen in daf-16(oe) animals (Fig. S4), which is
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Fig. 1 SKN-1 is required for daf-16(oe) Oxr but not Age. (A–C) skn-1 is required for daf-16(oe) Oxr. One representative trial shown in each case. (A) 5 mM t-BOOH. daf-16
(oe) increases survival by +14.1%, P < 0.0001 (log rank test; combined data from 3 trials). (B) 2.5 mM sodium arsenite. daf-16(oe) increases survival by +34.1%, P < 0.0001
(log rank test; representative data from 2 trials). (C) 100 mM Paraquat. daf-16(oe) increases survival by +34.2%, P < 0.0001 (log rank test; combined data from 3 trials). (D)
daf-16(oe) (zIs356) Age does not require SKN-1 (trial 1 in Table S1). (E,F) daf-16(oe) Age is not suppressed by skn-1 RNAi (both trial 1 in Table S1). (G) Age resulting from
intestine-specific daf-16(oe) is not suppressed by skn-1 RNAi (trial 1 in Table S1). Assays performed at 20 °C with 40 lM (D) or 80 lM FUDR (E–G).
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consistent with a previous study (Cabreiro et al., 2011). The latter trend
was not worsened by skn-1(zu135), but lessened (Fig. S4). Similar results
were also observed in trials using skn-1 RNAi (Fig. S4). Thus, daf-16(oe)
does not reduce overall levels of protein oxidation in skn-1 mutants.
We had previously identified skn-1 as potentially bound and
transcriptionally activated by DAF-16 (Schuster et al., 2010). To test this
further, we verified binding of DAF-16 to the skn-1 promoter, comparing
daf-2 and daf-16; daf-2 adults using chromatin immunoprecipitation
(ChIP) and PCR. Our previous chromatin profiles suggested two DAF-16
binding sites at the skn-1 locus (Fig. 2A). Re-examining this confirmed
DAF-16 binding to the skn-1b/c promoter (Fig. 2B).
mRNA profile data (microarrays) showed a 2.4-fold increase in skn-1
mRNA (q = 0.09) in glp-4(bn2); daf-2(m577) relative to daf-16(mgDf50)
glp-4; daf-2 in young adult hermaphrodites (McElwee et al., 2007).
However, comparison of skn-1 mRNA levels in daf-2(e1370) vs daf-16;
daf-2 animals using RT–QPCR did not confirm this (Fig. S5A). As an
additional test of DAF-16 regulation of skn-1 expression, we created
transgenic worm lines containing a Pskn-1b/c::gfp transcriptional
reporter and crossed them into daf-2(e1370) and daf-16; daf-2
backgrounds. In a WT genetic background Pskn-1b/c::GFP was
expressed in mesendodermal tissues (Fig. S5B), consistent with the
established role of SKN-1 in development (Blackwell et al., 2015) and
was broadly similar at all developmental stages. daf-2(e1370) increased
expression from this reporter (gfp mRNA levels), dependent upon daf-16
(Fig. 2C) consistent with direct activation of the skn-1b/c promoter by
DAF-16. GFP fluorescence was not changed by rIIS (Fig. S5C), but this
could reflect the global reduction of protein synthesis caused by daf-2
(e1370) (Depuydt et al., 2013).
To understand these results, we reasoned that skn-1 may possess a
latent capacity to be up-regulated by DAF-16 that becomes detectable
using the skn-1::GFP transgene array. This could reflect the increased
gene copy number in the array and/or greater stability of gfp mRNA
(Fig. 2C). Consistent with this interpretation, we detected an increase in
skn-1 mRNA levels in daf-16(oe) worms relative to WT using RT–PCR
(Fig. 2D). Together, these results suggest that by virtue of its DAF-16
binding site (Schuster et al., 2010) skn-1 has the capacity to be
upregulated by DAF-16 via binding to the skn-1b/c promoter. However,
this capacity remains latent in some contexts in which DAF-16 activity is
increased, and it is possible that it is only manifested under artificial
conditions such as daf-16 over-expression.
AMP-activated protein kinase (AMPK) is, like SKN-1, required for daf-
2 longevity and, like skn-1, it is directly up-regulated by DAF-16 (Tullet,
2014). AMPK also acts upstream of DAF-16 (Greer et al., 2007). We
therefore wondered whether daf-16(oe) Age might also be AMPK
independent. Mutation of the AMPK a subunit gene aak-2 fully
suppresses daf-2 longevity (Apfeld et al., 2004). However, aak-2 did
not suppress daf-16(oe) Age (Fig. S3C). That neither SKN-1 nor AMPK
are required for daf-16(oe) Age could imply that DAF-16 effectors that
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Fig. 2 Pskn-1b/c has the capacity for transcriptional activation by DAF-16/FoxO. (A) Schematic representation of the skn-1 locus. This shows the location of putative DAF-16
binding sites identified by DamID (Schuster et al., 2010) and ChIP Seq (Niu et al., 2011), and of ChIP PCR primers. (B) DAF-16 binds to Pskn-1b/c but not Pskn-1b. A DAF-16-
specific antibody (Santa Cruz) was used for ChIP. The horizontal dotted line indicates % input from a region 50 of Pskn-1b/c not predicted to bind DAF-16 (Schuster et al.,
2010). One representative experiment (of three) is shown which contained 3 IP replicates from the same chromatin preparation (mean  SD). (C) daf-16-dependent increase
in gfp mRNA levels in Pskn-1b/c::gfp daf-2 animals. *P < 0.05, mean  SD, 3 independent trials. Prior to transgene expression analysis animals were maintained at 15 °C
until the L4 stage and then shifted to 25 °C for 24 h. (D) skn-1 mRNA level is increased by daf-16(oe) (zIs356). *P < 0.05, mean  SD, 3 independent trials. (E)
Scheme showing the DAF-16/SKN-1 portion of the DAF-16 gene-regulatory network, based on the daf-16(oe) context where SKN-1 promotes Oxr but not Age. Dashed
arrow denotes context dependent capacity for transcriptional activation from Pskn-1b/c by DAF-16. Refer to supplement for methods to these and subsequent experiments.
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extend lifespan vary according to whether DAF-16 activation results from
rIIS or daf-16(oe) or, in the case of AMPK, may signify that DAF-16
activation circumvents the need for AMPK upstream.
To conclude, this study reveals that the effects of SKN-1 on Oxr and
Age can be separated, implying that promotion of longevity by SKN-1
can act by mechanisms other than oxidative stress resistance (Fig. 2E).
This is consistent with the general conclusion that oxidative damage
does not play a significant role in aging in C. elegans. SKN-1 also
transcriptionally regulates genes involved with other processes, for
example, autophagy and collagen synthesis and, like IIS, plays a role in
early development (Blackwell et al., 2015). Identification of the actual
effector mechanisms by which SKN-1 protects against aging is an
important future challenge, particularly given the evolutionary conserved
role of skn-1/Nrfs in the control of aging (Sykiotis & Bohmann, 2008).
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Fig. S1 Resistance to heat stress measured in liquid.
Fig. S2 skn-1 mutation does not affect the germline hyperplasia and basal
membrane disruption of the germline of daf-16(oe) animals.
Fig. S3 Tests for interactions between factors affecting lifespan.
Fig. S4 No difference in protein damage detected in response to skn-1
mutation or skn-1 RNAi in N2 or daf-16(oe) animals.
Fig. S5 skn-1 mRNA and Pskn-1b/c::GFP fluorescence levels.
Table S1 Statistics for lifespan measurements.
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